逆行开放肠系膜支架置入术治疗急性血栓性肠系膜缺血的结果
这项回顾性多中心研究纳入25例因闭塞性血栓性急性肠系膜缺血接受逆行开放肠系膜支架置入术(ROMS)的患者,技术成功率为92%,30天手术死亡率为25%,1年总体生存率为65%,1年一期通畅率为92%。作者认为ROMS技术成功率高、中期一期通畅率高,可作为经皮血管内血运重建不适用或失败时替代逆行肠系膜上动脉旁路术的选择。
要点
- ROMS治疗血栓性急性肠系膜缺血技术成功率达92%。
- 30天手术死亡率为25%,1年总体生存率为65%。
- 1年一期通畅率为92%,中期通畅性良好。
核心结论
- ROMS治疗血栓性急性肠系膜缺血具有较高的技术成功率和较高的中期一期通畅率。
- 对于经皮血管内血运重建不适用或失败的患者,ROMS可作为逆行肠系膜上动脉旁路术的替代术式。
研究设计与样本
- 回顾性多中心研究,纳入2012年11月至2017年3月三家三级医疗中心所有连续接受ROMS血运重建的闭塞性血栓性急性肠系膜缺血患者。
- 共纳入25例患者,其中男性14例、女性11例,平均年龄64.9±11.6岁。
主要发现
- 2例因无法再进入主动脉腔而ROMS未成功,技术成功率为92%。
- 1例需行两条内脏动脉血运重建并接受主动脉-肝动脉旁路术。
- 5例(20%)在逆行支架置入前接受肠系膜上动脉内膜切除加补片血管成形术。
- 30天手术死亡率为25%,1年总体生存率为65%,1年一期通畅率为92%。
关键数值与推荐
- 技术成功率为92%。
- 30天手术死亡率为25%。
- 1年总体生存率为65%。
- 1年一期通畅率为92%。
- 1例术后1个月影像显示支架移位至主动脉分叉处。
临床怎么用
- 对于经皮血管内血运重建不适用或失败的闭塞性血栓性急性肠系膜缺血患者,可考虑ROMS作为逆行肠系膜上动脉旁路术的替代术式。
- ROMS可结合血管内血运重建与小肠探查切除,但需注意术后支架移位等并发症并做好影像随访。
局限性
- 本研究为回顾性多中心研究,样本量较小(25例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Acute mesenteric ischemia (AMI) is an emergent event with a high mortality rate; survivors have high rates of intestinal failure. Restoration of blood flow using endovascular or surgical revascularization is associated with better outcome in terms of survival rate and intestinal resection. Retrograde open mesenteric stenting (ROMS), which is a hybrid technique, combines two benefits: prompt blood flow restoration with an endovascular approach and inspection and resection of the small bowel. The aim of the study was to assess the results of ROMS in thrombotic AMI in a retrospective multicenter study. METHODS: We retrospectively enrolled all consecutive patients who underwent ROMS revascularization for occlusive thrombotic AMI in three participating tertiary care centers between November 2012 and March 2017. RESULTS: Twenty-five patients (14 men and 11 women; mean age, 64.9 ± 11.6 years) were included. In two patients, ROMS was not possible because of failure of re-entry in the aortic lumen (technical success, 92%). One patient required revascularization of two visceral arteries and underwent an aortohepatic bypass. Five patients (20%) underwent endarterectomy and patch angioplasty of the superior mesenteric artery before retrograde stenting. Thirteen patients (52%) required bowel or colon resection (11 patients required both resections) during the initial procedure with a mean length of small bowel resection of 52 ± 87 cm. The 30-day operative mortality rate was 25%, and the overall 1-year survival rate was 65%. The 1-year primary patency rate was 92%. In one patient, postoperative imaging at 1 month showed stent migration in the aortic bifurcation. CONCLUSIONS: ROMS for thrombotic AMI has a high technical success rate and a high midterm primary patency rate. It could be an alternative procedure to retrograde superior mesenteric artery bypass for patients when percutaneous endovascular revascularization is not indicated or has failed.
引用
- Roussel A, Della Schiava N, Coscas R, et al. Results of retrograde open mesenteric stenting for acute thrombotic mesenteric ischemia. J Vasc Surg. 2019. PMID: 30777691. doi:10.1016/j.jvs.2018.07.058
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。